Cargando…
Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
Tuberculosis (TB) is considered as one of the most serious threats to public health in many parts of the world. The threat is even more severe in the developing countries where there is a lack of advanced medical amenities and contemporary anti-TB drugs. In such situations, dosage optimization of ex...
Autores principales: | Xu, Yuhui, Wu, Jianan, Liao, Sha, Sun, Zhaogang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627446/ https://www.ncbi.nlm.nih.gov/pubmed/28974222 http://dx.doi.org/10.1186/s12941-017-0239-4 |
Ejemplares similares
-
Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China
por: Jia, Hongbing, et al.
Publicado: (2021) -
Profile of tuberculosis and its response to anti-TB drugs among tuberculosis patients treated under the TB control programme at Felege-Hiwot Referral Hospital, Ethiopia
por: Zenebe, Yohannes, et al.
Publicado: (2016) -
Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019) -
In vivo evolution of drug-resistant Mycobacterium tuberculosis in patients during long-term treatment
por: Xu, Yuhui, et al.
Publicado: (2018) -
The Correlations of Minimal Inhibitory Concentration Values of Anti-TB Drugs with Treatment Outcomes and Clinical Profiles in Patients with Multidrug-Resistant Tuberculosis (MDR-TB) in China
por: Tang, Qin, et al.
Publicado: (2022)